JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE) ›› 2020, Vol. 40 ›› Issue (5): 674-678.doi: 10.3969/j.issn.1674-8115.2020.05.019

• Review • Previous Articles     Next Articles

Recent advance in association of galectin-3 with atrial fibrillation

YANG Xin-ying1, GAO Yi2, MIAO Cong-liang3, DING Xiao-ying4, HONG Jiang1, 3   

  1. 1. Shanghai General Hospital of Nanjing Medical University, Shanghai 200080, China; 2. Department of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai 200080, China; 3. Department of Emergency, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai 200080, China; 4. Department of Endocrinology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai 200080, China
  • Online:2020-05-28 Published:2020-05-28
  • Supported by:
    National Natural Science Foundation of China (81570293, 81870594).

PDF (PC)

728

Abstract: Atrial fibrillation is a common cardiac arrhythmia encountered in the clinical practice with a complex pathological mechanism, which is closely related to structural remodeling such as atrial fibrosis. Galectin-3 (Gal-3) is the only chimeric member of the galectin family and is considered as a biomarker of fibrosis; therefore, it may be involved in atrial remodeling in the patients with atrial fibrillation. This article reviews literatures on the association of Gal-3 with atrial fibrillation.

Key words: galectin-3 (Gal-3), atrial fibrillation, atrial fibrosis

CLC Number: